Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants
Status:
Completed
Trial end date:
2020-04-22
Target enrollment:
Participant gender:
Summary
TolaSure is a topical gel for the promotion of accelerated wound healing. This phase II study
will primarily assess the efficacy of TolaSure when applied to skin wounds created by punch
biopsy in healthy participants. Safety, cutaneous tolerability, wound pain control, and
quality of healing will also be assessed. A total of 80 healthy volunteers, males and females
ages 18 years or older, will be enrolled. Subjects will be monitored for safety and efficacy
until wound closure (estimation about 8 weeks) following topical administration of TolaSure.